Clearmind advances dialogue with U.S. government on psychedelic therapies, submits FDA recommendations
CMND•Clearmind Medicine said it submitted recommendations to the FDA on psychedelic therapies and called for research and clinical collaborations with the VA, DOW and HHS.
1. FDA recommendations
Clearmind Medicine said it submitted recommendations to the FDA as it advances dialogue with the U.S. federal government on psychedelic therapies. The company also called for research and clinical collaborations with the VA, DOW and HHS.
